# Study Assessing Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MGTA-145 in Healthy Volunteers as a Single Agent or in Combination With Plerixafor

> **NCT03932864** · PHASE1 · COMPLETED · sponsor: **Ensoma** · enrollment: 107 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **BIOLOGICAL:** MGTA-145
- **BIOLOGICAL:** plerixafor
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT03932864
- **Lead sponsor:** Ensoma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-22
- **Primary completion:** 2020-02-25
- **Final completion:** 2020-02-25
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2024-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03932864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03932864, "Study Assessing Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MGTA-145 in Healthy Volunteers as a Single Agent or in Combination With Plerixafor". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03932864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*